Navigation Links
Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
Date:12/20/2007

e all over the world. In particular, about 20% to 30% of the U.S. population complains of waking too early several times a week, a symptom of sleep maintenance insomnia (SMI) that is characterized by symptoms that include waking up frequently during the night with difficulty returning to sleep, waking up at early hours, and unrefreshing sleep. The majority of sleep complaints are related to SMI rather than sleep initiation or difficulty in falling asleep. However, there are no drugs currently approved in the U.S. that address only SMI. Furthermore, current sleep medications typically induce sedation and result in significant increases in daytime sleepiness that impairs quality of life in these patients. There is, therefore, a significant need for sleep medications that improve sleep quality without next-day hangover effects.

ABOUT ITI-722

ITI-722 is a highly potent 5HT2A antagonist for the treatment of sleep maintenance insomnia. Preclinical data has shown that ITI-722 is not sedating and should not exhibit next-day hangover effects that are commonly associated with other sleep medications. ITI-722 is expected to have a strong safety profile with no addiction liability. This compound is being evaluated for the treatment of sleep disorders in various patient populations with sleep maintenance problems and in other sleep disorders where staying asleep affects the quality of life, including nocturnal awakenings related to osteoarthritic pain, hot flashes in post-menopausal women and many psychiatric and neurodegenerative diseases.

ABOUT CNSProfile(TM)

The Company has developed a state-of-the-art technology platform, called CNSProfile(TM), that is capable of generating a unique molecular signature for drug compounds. Specifically, CNSProfile(TM) measures the levels of phosphoproteins, proteins chemically linked at specific sites to phosphates. This profile provides the Company with a proprietary and unique window into the intracellular action
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intra-Cellular Therapies Presents Preclinical Data From Schizophrenia and Sleep Maintenance Programs
2. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
3. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
7. Vital Therapies Announces Presentation of ELAD(R) Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
8. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
9. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... clinical trial manufacturing, and advanced analytical and consulting services ... participate at the upcoming Rodman & Renshaw 16 th ... New York . The Company will ... 2014 at the New York Palace Hotel. ...
(Date:8/27/2014)... LYNDHURST N.J. and NINGBO, China ... ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") ... regarding the development of generic pharmaceuticals, primarily targeting ... terms of the agreement, Amerigen and Menovo will jointly ... the United States . Menovo will be responsible ...
(Date:8/27/2014)... ON , Aug. 27, 2014 /CNW/ - Covalon Technologies ... technologies company, announces the following financial results for its third ... ended June 30, 2014: , Revenue of $1,291,378, ... year , Net loss for the quarter of $240,156 ... of the prior year For the nine ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... COVE, N.Y., Sept. 8 In response to the news ... issued a recall of its ASR product line after data ... five years after the initial procedure, Dr. Eugene S. Krauss, ... Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member ...
... the Indiana State Legislature,s Criminal Law and Sentencing Policy ... state can improve its policies for preventing the illegal ... leading cold and allergy medicines - for methamphetamine production. ... from requiring a prescription for currently accessible medicines like ...
Cached Medicine Technology:Patients Should Expect 'Long Life' from their Joint Replacements! 2Indiana State Legislators Seek Solutions to Combat Illegal Meth Production 2Indiana State Legislators Seek Solutions to Combat Illegal Meth Production 3
(Date:8/27/2014)... While many scientists are trying to prevent the ... autophagy, researchers at Virginia Commonwealth University Massey Cancer ... that causes the process to culminate in cell ... targets the p62 protein, which is often referred ... role in disposing unwanted cellular proteins during autophagy. ...
(Date:8/27/2014)... August 27, 2014 Representatives with ... Italy to its list of destinations for International Yoga ... Recharge Retreats, explained that the company chose Italy due ... for yoga teacher trainings since it's an easy flight ... for people traveling from all over Europe, UK, Africa, ...
(Date:8/27/2014)... Lighthouse Payment Services Inc ., a ... will exhibit its image-based lockbox services at the Independent ... in beautiful Lake Placid, New York from September ... held at the Lake Placid Convention Center and will ... in addition to a variety of vendors exhibiting the ...
(Date:8/27/2014)... Sugar Manufacturing in Australia ... in global supply and demand, which have contributed to ... industry derives a large share of its revenue from ... dynamics, with supply and prices being determined by larger ... Australian dollar for the majority of the past five ...
(Date:8/27/2014)... SCOTT Sports is excited to ... indoor mountain bike and BMX park. SCOTT will provide ... both adult and youth sizes for the park’s rental bike ... warehouse in Ogden, Utah, recently moved its U.S. headquarters from ... proud to be a partner with the Wasatch Bike Park, ...
Breaking Medicine News(10 mins):Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2
... MORGANTOWN, W.Va., April 17 Even though suicide outranks ... States, incomplete death certificates thwart healthcare policymakers who want ... Hispanic populations, a WVU study shows."The Institute ... commit suicide have been diagnosed with a mental disorder, ...
... LAUDERDALE, Fla., April 17 Former partner and accomplished ... & Scherer LLP as a partner.Genovese, most recently of ... has tried over 150 jury trials and has had ... Times and the Wall Street Journal. He is well ...
... 17 Recent economic events have led people to ... families. Many are feeling that it is time to ... and they are deciding to start their families now, ... cocooning is reflected in a growing number of couples ...
... 17 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: ... its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), ... for the purchase of all outstanding Ordinary Shares of ... now expire at 5:00 p.m., New York City time, ...
... April 30, 2009 - 9:00 a.m. ET HOPKINTON, Mass., ... CALP ) will conduct a conference call discussing ... a.m. ET on Thursday, April 30. Kevin Hrusovsky, ... Financial Officer, will host the call. Management will discuss ...
... 19 - April 25 HARRISBURG, Pa., April 17 ... for selflessly giving their time to help communities prepare ... to join those important efforts. "National Volunteer Week starts ... volunteers for generously sharing their time, energy and expertise ...
Cached Medicine News:Health News:Team Uncovers Discrepancy in Death Certificates Listing Suicide 2Health News:Veteran Medical Malpractice Litigator Gary S. Genovese Re-Joins Conrad & Scherer LLP 2Health News:Family Cocooning in the Face of Recession Leads to Expanded Business for Bay Area Fertility Doctor - Dr. Danielle Lane 2Health News:Sun Pharmaceutical Extends Tender Offer for Taro 2Health News:Sun Pharmaceutical Extends Tender Offer for Taro 3Health News:Caliper Life Sciences' First Quarter 2009 Financial Results Conference Call Notice 2Health News:PA Secretary of Health Recognizes Pennsylvania Volunteers; Urges Greater Citizen Involvement 2
Inoculum Broth...
... Molecular Biology Buffers are ready-to-use solutions ideal ... applications. Each reagent is prepared with 18 ... filter, and filled into sterile bottles., ... control standards to ensure lot-to-lot consistency. ...
1.2% Tryptone, 2.4% Yeast Extract, 0.4% Glycerol, with 100ml of 10x Phosphate buffer supplement (0190-01)....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
Medicine Products: